✦ LIBER ✦

PND39 What is the Influence on Clinical Research of the EMA Guideline on Medicinal Products for the Treatment of Alzheimer's Disease?

✍ Scribed by M. Caron; C. Acquadro; M.P. Emery

Book ID: 119311726
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 58 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.03.798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A review and commentary on a sample of 1

A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease

✍ Richard J. Harvey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

Background. There has been widespread development of clinical guidelines for the treatment of Alzheimer's disease since the introduction of donepezil in the UK in 1997. These have been developed nationally, regionally, locally and by independent groups. An independent review of guidelines available

Commentary on “Health economics and the

Commentary on “Health economics and the value of therapy in Alzheimer’s disease.” Drug treatment of Alzheimer’s disease: The United Kingdom experience—National Institute for Health and Clinical Excellence guidance and guidelines for dementia

✍ Roy Jones 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Commentary on “A roadmap for the prevent

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Centers of excellence in Alzheimer's disease: It is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease

✍ Rachelle S. Doody 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Research on the actual condition for dia

Research on the actual condition for diagnoses and treatments of depression in patients with Alzheimer's disease and/or cerebrovascular disease in Japan

✍ Megumi Takahashi; Hiroshi Kimotsuki; Hisatoshi Arai; Yumiko Kitamura; Chisako Sh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Commentary on Wim Dekkers’s and Marcel O

Commentary on Wim Dekkers’s and Marcel Olde Rikkert’s: “What is a genetic disease? The example of Alzheimer’s Disease” and Stephen Tyreman’s: “Causes of illness in clinical practice: A conceptual exploration”

✍ Lennart Nordenfelt 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 138 KB

Commentary on “A roadmap for the prevent

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” “Big Asks”: What can be changed to increase and speed progress on Alzheimer's disease research and treatment?

✍ Walter A. Kukull 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 154 KB